Aktiesnakken — April 2010
-
min port pånær genmab grønnedes pludseligt
-
---------- GSK CC 28 April -----------
-
jeg kører cc GSK på IR live chat
-
Witty er glad for sit regnskab. A fabulous quarter for our consumer care
-
de har skabt en diversificeret forretning
-
tak aka
-
både på produktpaletten og i emerging markets
-
sensodyne er den hurtigst voksende tandpasta i US
-
intet nyt om arzerra, men tykerb er nævnt men 62% vækst
-
dermatologist skal gøres global
-
stiefl skal til india,china og japan
-
synergierne er på vej og på sporet og leverer 2,2 mia pund i 2011
-
sales growth
-
så kom Arzerra godkendelsen!
-
continue to see progress in approval
-
30 major programs in phase 3 hele tiden
-
2,2 billion costsaving i 2012
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind